HPN-01
- Generic Name
- HPN-01
A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Hepanova Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT04481594
- Locations
- 🇺🇸
Frontage Clinical Services, Inc, Secaucus, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath